The world of type 2 diabetes drugs is wacky indeed. While Amylin’s long-acting version of Byetta — called Bydureon and predicted by many experts to become a blockbuster — is still held up at FDA, the agency approved a new oral drug earlier this month that is reportedly unremarkable except in the lawsuit it has spurred.
The drug is called linagliptin, brand name Tradjenta, a new oral DPP-4 inhibitor from Eli Lilly and Boehringer that…
Read more »
John Steuart is Managing Director at Claremont Creek Ventures, a VC firm in Silicon Valley that invests in information technology and life sciences companies. Their tagline is: “We seek passionate entrepreneurs with disruptive technologies who want to change the world.”
We’re delighted to have John join us again this year as a judge in the DiabetesMine Design Challenge. In case you missed this morning’s bulletin: CONTEST VOTING CLOSES TODAY AT 6pm PST, so take 2…
Read more »
Hi All,
Please spread the word today: It’s your last chance to vote in the 2011 DiabetesMine Design Challenge. Polls close tonight at 6pm Pacific time.
We want to congratulate each of our finalists! From 95 entries this year, our judging team narrowed the field to 20 designs in the Grand Prize category, four as “Most Creative” favorites, and three top contenders in the Kids’ category.
As a reminder:
Your votes will determine the winners…
Read more »
When it comes to diabetes, no place is safe. We have featured folks with diabetes from Spain to Germany to Canada and now we’re traveling across the globe to Australia to hear from Simon, a 35-year-old with LADA.
Simon lives in South Australia where he works in antiques, and despite living in the sixth largest country in the world (and an entire continent!), he’s found that the Australian Diabetes Online Community is pretty small compared…
Read more »
